Le Lézard
Classified in: Environment, Health
Subjects: RCY, ENI

Thermo Fisher Scientific Commits to Achieve Net-Zero Carbon Emissions by 2050


WALTHAM, Mass., July 27, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced its commitment to achieve net-zero carbon emissions by 2050. This supports the global goals of the Paris Climate Agreement and the United Nations' Race To Zero campaign and will further advance the company's current strategy to mitigate its impact on the environment.

Thermo Fisher's carbon reduction efforts build on its 2030 targets to reduce greenhouse gas (GHG) emissions across its operations (Scopes 1 and 2). Established in 2019, these goals are aligned with the criteria of the Science Based Targets initiative (SBTi). Thermo Fisher's new pledge to reach carbon neutrality by 2050 incorporates additional targets to reduce its value chain emissions (Scope 3), including a commitment to SBTi's most ambitious guidelines.

"To better serve our customers and society overall, we continue to build on our commitment to sustainability," said Marc N. Casper, chairman, president and chief executive officer, Thermo Fisher Scientific. "At Thermo Fisher, we have a culture of continuous improvement, which is powered by our PPI Business System. Our goal to find a better way every day inspires our colleagues to drive innovation and deliver new solutions. The effort to achieve net-zero emissions by 2050 will further engage all 80,000 of our colleagues to address climate change."

Meeting a net-zero commitment for the future requires innovating today. Thermo Fisher is moving forward on this front by making its facilities more energy efficient, increasing the use of renewable energy and reducing waste in its operations. The company also plays a critical role in advancing climate science as a whole. Its leading analytical instruments spur the creation of green technologies and allow researchers to further investigate global warming. All of these efforts will help enable customers and partners to achieve their climate goals.

Casper continued, "Our goal to achieve carbon neutrality is another example of our commitment to doing business the right way and our mission to enable our customers to make the world healthier, cleaner and safer. We are taking deliberate actions today to strengthen our business for tomorrow's customers, colleagues and communities."  

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com.

Media Contact Information:
Ron O'Brien
Thermo Fisher Scientific
Phone: 781-622-1242
E-mail: [email protected]  

Investor Contact Information:
Rafael Tejada
Thermo Fisher Scientific
Phone:  781-622-1356
E-mail: [email protected]

SOURCE Thermo Fisher Scientific


These press releases may also interest you

at 08:15
AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of two senior management team members. Chris Horvath, MS, MBA - Chief Commercial and...

at 08:14
The pace of companies' transitions to intelligent automation is accelerating: 60% are looking to explore new usage or increase their usage of advanced technologies over the next 18 months.Today, while more than 75% of organizations claim they now...

at 08:10
Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the appointment of Dana Alexander as Chief Technical Officer. "Dana has over two decades of operational expertise...

at 08:07
Lindus Health, an anti-CRO running radically faster, more reliable clinical trials for life science pioneers, is announcing the appointment of Dr. Tim Garnett, pharma industry leader and former Chief Medical Officer at Eli Lilly, to their advisory...

at 08:07
Testmate Health, a pioneer in at-home testing solutions, has secured USD $6 million in seed funding to develop an industry-first, low-cost, over-the-counter , self-test for sexually transmitted infections (STI), starting with chlamydia and...

at 08:07
4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA)...



News published on and distributed by: